Literature DB >> 11356299

Phase-shifting effects of pituitary adenylate cyclase activating polypeptide on hamster wheel-running rhythms.

H D Piggins1, E G Marchant, D Goguen, B Rusak.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP38) is a putative neurochemical of the main retinal input to the mammalian circadian pacemaker housed in the suprachiasmatic nucleus (SCN). We assessed the phase-resetting effects of microinjection of PACAP38 into the SCN region on hamster wheel-running rhythms. When administered during the middle of the subjective day, PACAP38 evoked large but transient phase advances ( approximately 60 min), that were followed by small, steady-state phase delays. During the early subjective night, PACAP38 elicited small to moderate phase delays without any detectable concentration-dependence. Late in the subjective night, PACAP38 had no significant effects. Saline microinjection had no effect at any phase tested. These findings show that PACAP38 has small to moderate effects on the phase of the hamster SCN circadian pacemaker, including significant phase delays early in the subjective night.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356299     DOI: 10.1016/s0304-3940(01)01796-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Neuropeptide-mediated calcium signaling in the suprachiasmatic nucleus network.

Authors:  Robert P Irwin; Charles N Allen
Journal:  Eur J Neurosci       Date:  2010-10-12       Impact factor: 3.386

2.  BIOLOGICAL TIMEKEEPING.

Authors:  Martha U Gillette; Sabra M Abbott
Journal:  Sleep Med Clin       Date:  2009-06-01

3.  Altered calmodulin response to light in the suprachiasmatic nucleus of PAC1 receptor knockout mice revealed by proteomic analysis.

Authors:  Jan Fahrenkrug; Jens Hannibal; Bent Honoré; Henrik Vorum
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes.

Authors:  Boglarka Racz; Gabriella Horvath; Nandor Faluhelyi; Andras D Nagy; Andrea Tamas; Peter Kiss; Ferenc Gallyas; Gabor Toth; Balazs Gaszner; Valer Csernus; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-07-01       Impact factor: 3.444

5.  Mass spectrometry-based discovery of circadian peptides.

Authors:  Nathan G Hatcher; Norman Atkins; Suresh P Annangudi; Andrew J Forbes; Neil L Kelleher; Martha U Gillette; Jonathan V Sweedler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

6.  Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus.

Authors:  Stephan Michel; Jason Itri; Jung H Han; Kathryn Gniotczynski; Christopher S Colwell
Journal:  BMC Neurosci       Date:  2006-02-16       Impact factor: 3.288

7.  NMDA and PACAP receptor signaling interact to mediate retinal-induced scn cellular rhythmicity in the absence of light.

Authors:  Ian C Webb; Lique M Coolen; Michael N Lehman
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

8.  Pituitary Adenylate Cyclase-Activating Peptide (PACAP)-Glutamate Co-transmission Drives Circadian Phase-Advancing Responses to Intrinsically Photosensitive Retinal Ganglion Cell Projections by Suprachiasmatic Nucleus.

Authors:  Peder T Lindberg; Jennifer W Mitchell; Penny W Burgoon; Christian Beaulé; Eberhard Weihe; Martin K-H Schäfer; Lee E Eiden; Sunny Z Jiang; Martha U Gillette
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.